Trump Admin Limits COVID Vaccine Access | JQJO

The Trump administration's FDA announced new restrictions on COVID-19 vaccine approvals, limiting fall booster shots to seniors and high-risk individuals. This policy shift, published in the New England Journal of Medicine, requires larger studies for healthier populations before widespread approval, marking a departure from previous annual recommendations for all adults. The decision has sparked criticism from experts concerned about reduced vaccine access and insurance coverage, potentially impacting millions who previously received annual boosters. This comes after the FDA's recent approval of Novavax's vaccine with similar restrictions and follows a series of moves under Health Secretary Robert F. Kennedy Jr. to scrutinize COVID-19 vaccine use.